MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 1, 2005; DOI: 10.1124/mol.105.014720


0026-895X/05/6806-1534-1542$20.00
Mol Pharmacol 68:1534-1542, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.014720v1
68/6/1534    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, Q.
Right arrow Articles by Wang, M.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, Q.
Right arrow Articles by Wang, M.-W.

Stereospecific Induction of Nuclear Factor-{kappa}B Activation by Isochamaejasmin

Qinghai Tian, Jing Li, Xin Xie, Meiling Sun, Hairong Sang, Caihong Zhou, Tianying An, Lihong Hu, Richard D. Ye, and Ming-Wei Wang

The National Center for Drug Screening, Shanghai Institute of Materia Medica (X.X., M.S., C.Z., T.A., L.H., M.-W.W.) and the Graduate School (Q.T.), Chinese Academy of Sciences, Shanghai, China; and Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (J.L., H.S., R.D.Y.)

The root of Stellera chamaejasme L. is a traditional Chinese herb termed Rui Xiang Lang Du and has been used to treat solid tumors, tuberculosis and psoriasis. Exactly how S. chamaejasme L. regulates cellular responses remains unclear. We examined four biflavonoids isolated from S. chamaejasme L., including isochamaejasmin, two of its stereo-isomers and a methyl derivative, in functional assays originally designed to screen ligands for the G protein-coupled formyl peptide receptor-like 1 (FPRL1). Isochamaejasmin was found to induce the expression of a nuclear factor (NF)-{kappa}B-directed reporter gene in transfected HeLa cells with an EC50 of 3.23 µM, independently of FPRL1. The isochamaejasmin-stimulated NF-{kappa}B reporter activity was accompanied by nuclear translocation of NF-{kappa}B proteins and was blocked by a dominant-negative construct of I{kappa}B{alpha}. Isochamaejasmin also induced time-dependent phosphorylation of the mitogen-activated protein kinases extracellular signal-regulated kinase 1/2 and p38, and a novel protein kinase C (PKC{delta}). Likewise, inhibition of these kinases with the respective pharmacological inhibitors significantly reduced the isochamaejasmin-stimulated NF-{kappa}B activation. It is noteworthy that the two stereoisomers and the methyl derivative did not induce detectable activation of NF-{kappa}B and were more cytotoxic than isochamaejasmin, which could partially rescue cycloheximide-induced apoptosis. Inhibition of NF-{kappa}B activation reversed the anti-apoptotic effect of isochamaejasmin. These results provide the first evidence for a potential mechanism of action by S. chamaejasme L., and indicate that structurally similar compounds derived from S. chamaejasme L. may have different pharmacological properties.


Received May 10, 2005; accepted September 1, 2005

Address correspondence to: Ming-Wei Wang, the National Center for Drug Screening, 189 Guo Shou Jing Road, Shanghai 201203, China. E-mail: center{at}mail.shcnc.ac.cn




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. Zhou, S. Zhang, M. Nanamori, Y. Zhang, Q. Liu, N. Li, M. Sun, J. Tian, P. P. Ye, N. Cheng, et al.
Pharmacological Characterization of a Novel Nonpeptide Antagonist for Formyl Peptide Receptor-Like 1
Mol. Pharmacol., October 1, 2007; 72(4): 976 - 983.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Yan, M. Nanamori, M. Sun, C. Zhou, N. Cheng, N. Li, W. Zheng, L. Xiao, X. Xie, R. D. Ye, et al.
The Immunosuppressant Cyclosporin A Antagonizes Human Formyl Peptide Receptor through Inhibition of Cognate Ligand Binding
J. Immunol., November 15, 2006; 177(10): 7050 - 7058.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics